"Mutation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.
| Descriptor ID |
D009154
|
| MeSH Number(s) |
G05.365.590
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Mutation".
Below are MeSH descriptors whose meaning is more specific than "Mutation".
This graph shows the total number of publications written about "Mutation" by people in this website by year, and whether "Mutation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 24 | 21 | 45 |
| 1997 | 26 | 16 | 42 |
| 1998 | 23 | 35 | 58 |
| 1999 | 14 | 33 | 47 |
| 2000 | 27 | 40 | 67 |
| 2001 | 15 | 47 | 62 |
| 2002 | 21 | 49 | 70 |
| 2003 | 19 | 76 | 95 |
| 2004 | 20 | 61 | 81 |
| 2005 | 23 | 83 | 106 |
| 2006 | 25 | 72 | 97 |
| 2007 | 27 | 56 | 83 |
| 2008 | 26 | 67 | 93 |
| 2009 | 25 | 70 | 95 |
| 2010 | 33 | 67 | 100 |
| 2011 | 35 | 85 | 120 |
| 2012 | 46 | 69 | 115 |
| 2013 | 42 | 68 | 110 |
| 2014 | 43 | 82 | 125 |
| 2015 | 48 | 99 | 147 |
| 2016 | 41 | 98 | 139 |
| 2017 | 34 | 85 | 119 |
| 2018 | 49 | 107 | 156 |
| 2019 | 52 | 77 | 129 |
| 2020 | 40 | 100 | 140 |
| 2021 | 27 | 89 | 116 |
| 2022 | 8 | 86 | 94 |
| 2023 | 3 | 91 | 94 |
| 2024 | 35 | 65 | 100 |
| 2025 | 28 | 41 | 69 |
| 2026 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mutation" by people in Profiles.
-
Spectrum, prevalence, and clinical correlates of PPM1D mutations in patients with clonal hematopoiesis and clonal cytopenias. Blood Adv. 2026 Mar 10; 10(5):1746-1755.
-
Characterization of chromosome 5 aberrations in TP53 mutated myeloid neoplasms with =5% blasts: An International TP53 Investigators Network (iTiN) study. Cancer. 2026 Jan 01; 132(1):e70210.
-
Contemporary data in myeloproliferative neoplasm-unclassifiable: mutational landscape and management of the 'unclassifiable'. Curr Opin Hematol. 2026 Mar 01; 33(2):45-50.
-
Papillary renal cell carcinoma, formerly known as Type 2: a single institutional study addressing histologic and molecular features. Histopathology. 2026 Apr; 88(5):1044-1050.
-
Genomic Landscapes of Endometrioid and Mucinous Ovarian Cancers and Morphologically Similar Tumor Types. Cancer Res Commun. 2025 Nov 01; 5(11):1952-1966.
-
Dual MAPK/VEGF inhibition for KRAS-mutated brain arteriovenous malformations. J Neurosurg. 2026 Feb 01; 144(2):452-461.
-
Somatic Mutation Profiles of Colorectal Cancer by Birth Cohort. JCO Precis Oncol. 2025 Oct; 9:e2500717.
-
Mutational signature analysis of chronic lymphocytic leukemia uncovering genomic patterns and prognostic implications. Am J Clin Pathol. 2025 Oct 04; 164(4):530-544.
-
Leukemia mutated proteins PHF6 and PHIP form a chromatin complex that represses acute myeloid leukemia stemness. Genes Dev. 2025 Oct 01; 39(19-20):1219-1240.
-
SMAD4 induces opposite effects on metastatic growth from pancreatic tumors depending on the organ of residence. Nat Cancer. 2025 Nov; 6(11):1839-1856.